Peapack-Gladstone Financial Corp’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Other funds holding BBH
MIM
CCA
BFG
Peapack-Gladstone Financial Corp's BBH Position: Q2 2026 in Review
Peapack-Gladstone Financial Corp reduced its VanEck Biotech ETF (BBH) stake by 8.5% in Q2 2026, selling an estimated $116K and leaving 6,588 shares worth $1.34M. The position accounts for 0.02% of the portfolio, ranked #385.
Peapack-Gladstone Financial Corp first reported a position in BBH in Q3 2022 and has held it in 16 quarters since. The position peaked at $4.78M in Q1 2023. 110 funds tracked by Wall St. Rank hold BBH as of Q2 2026.
- Peapack-Gladstone Financial Corp held 6,588 shares of VanEck Biotech ETF worth $1.34M as of Q2 2026.
- Peapack-Gladstone Financial Corp sold 615 VanEck Biotech ETF shares in Q2 2026, an estimated $116K.
- VanEck Biotech ETF made up 0.02% of Peapack-Gladstone Financial Corp's portfolio in Q2 2026, its #385 holding.
- Peapack-Gladstone Financial Corp first reported a position in VanEck Biotech ETF in Q3 2022 and has held it in 16 quarters since.
- Peapack-Gladstone Financial Corp's VanEck Biotech ETF position peaked at $4.78M in Q1 2023.
- 110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.
Based on Peapack-Gladstone Financial Corp's 13F filing for Q2 2026, filed 14 Aug 2026.